Helminthiasis (Parasitic Worm Infestation) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Helminthiasis (Parasitic Worm Infestation) – Drugs In Development, 2024 report and make more profitable business decisions.
Helminthiasis, also known as worm infection, is any macroparasitic disease of humans or other animals in which a part of the body is infected with parasitic worms, known as helminths. There are numerous species that are not necessarily related, and are broadly classified into tapeworms, flukes, and roundworms. They often live in the gastrointestinal tract of their hosts, but they may also burrow into other organs, where they cause physiological damage.
The Helminthiasis (Parasitic Worm Infestation) drugs in development market research report provide comprehensive information on the therapeutics under development for Helminthiasis (Parasitic Worm Infestation), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Helminthiasis (Parasitic Worm Infestation) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Helminthiasis (Parasitic Worm Infestation) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 20 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Helminthiasis (Parasitic Worm Infestation) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Helminthiasis (Parasitic Worm Infestation) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Helminthiasis (Parasitic Worm Infestation) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbGenics Life Sciences Pvt LtdAlbert B. Sabin Vaccine Institute Inc
Bayer AG
Cardiff University
Farmabrasilis
Helix Biogen Institute
ISGlobal Barcelona Institute for Global Health
Medicines Development for Global Health Ltd
Merck KGaA
Oswaldo Cruz Foundation
QIMR Berghofer Medical Research Institute
Salvensis
Tongli Biomedical Co Ltd
University of California San Diego
University of Queensland
University of Washington
Villya Pharmaceuticals
Zero Point Five Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Helminthiasis (Parasitic Worm Infestation) reports